Outset Medical (OM) Competitors

Outset Medical (NASDAQ:OM) and Perspective Therapeutics (NYSE:CATX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, community ranking, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.

Which has preferable earnings & valuation, OM or CATX?

Perspective Therapeutics has lower revenue, but higher earnings than Outset Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$113.69M	0.30	-$172.80M	-$37.18	-0.26
Perspective Therapeutics	$1.43M	96.32	-$46.51M	N/A	N/A

Does the MarketBeat Community prefer OM or CATX?

Perspective Therapeutics received 9 more outperform votes than Outset Medical when rated by MarketBeat users. Likewise, 97.06% of users gave Perspective Therapeutics an outperform vote while only 38.10% of users gave Outset Medical an outperform vote.

Company	Underperform	Outperform
Outset Medical	Outperform Votes 24 38.10%	Underperform Votes 39 61.90%
Perspective Therapeutics	Outperform Votes 33 97.06%	Underperform Votes 1 2.94%

Does the media favor OM or CATX?

In the previous week, Perspective Therapeutics had 14 more articles in the media than Outset Medical. MarketBeat recorded 16 mentions for Perspective Therapeutics and 2 mentions for Outset Medical. Outset Medical's average media sentiment score of 1.89 beat Perspective Therapeutics' score of 0.67 indicating that Outset Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Outset Medical	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Very Positive
Perspective Therapeutics	6 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders hold more shares of OM or CATX?

54.7% of Perspective Therapeutics shares are owned by institutional investors. 4.1% of Outset Medical shares are owned by company insiders. Comparatively, 3.5% of Perspective Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more volatility and risk, OM or CATX?

Outset Medical has a beta of 1.91, indicating that its share price is 91% more volatile than the S&P 500. Comparatively, Perspective Therapeutics has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500.

Is OM or CATX more profitable?

Outset Medical has a net margin of -112.57% compared to Perspective Therapeutics' net margin of -4,096.66%. Perspective Therapeutics' return on equity of -27.40% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-112.57%	-175.64%	-38.61%
Perspective Therapeutics	-4,096.66%	-27.40%	-23.16%

Do analysts prefer OM or CATX?

Outset Medical presently has a consensus target price of $35.00, suggesting a potential upside of 264.58%. Perspective Therapeutics has a consensus target price of $12.75, suggesting a potential upside of 585.48%. Given Perspective Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Perspective Therapeutics is more favorable than Outset Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Perspective Therapeutics	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	3 Strong Buy rating(s)	3.18

Summary

Perspective Therapeutics beats Outset Medical on 12 of the 17 factors compared between the two stocks.